A hemoglobin-supplemented medium composed of Columbia agar base supplemented with 1% hemoglobin and 1% Polyvitex was used to investigate the in vitro activity of 29 antimicrobial agents against Capnocytophaga species. Clindamycin was the most active agent, with all strains being inhibited by 0.06 pg/ml or less. Amoxicillin-clavulanic acid and imipenem were the most active among the beta-lactam antibiotics (MIC for 90% of strains tested [MIC90], 0.50 ,ug/ml); other very active drugs were BMY 28142, cefpirome, cefotaxime, ceftazidime, and ceftriaxone (MIC90, 0.06 to 0.50 p,g/ml), although at least one strain showed resistance to each of these antibiotics (MIC, .16 ,ug/ml). Ciprofloxacin was the most active among the quinolones, with all strains being inhibited by 0.50 pg/mi. The MICs of the other four drugs ranged from 0.12 to 4 ,ug/ml. Ampicillin, penicillin G, ticarcillin, aztreonam, and temocillin were moderately active (MIC90, 1 to 8 ,ug/ml; MIC range, c0.03 to >12& ,ug/ml). All strains were uniformly resistant to the aminoglycosides, polymyxin 1l, vancomycin,
Capnocytophaga spp. are described as facultative, anaerobic, fastidious, gram-negative rods (12, 14, 21) . They have been identified as part of the normal gingival flora in humans and are involved in the etiology of localized juvenile periodontitis (16) . Severe infections in compromised as well as in noncompromised patients have been reported from many centers (1-4, 7-11, 18, 20, 24) . Previously described susceptibility tests of Capnocytophaga spp. have been performed on a small number of strains by different methods (6, 15, 22) . In this study we evaluated a hemoglobin-supplemented medium that can be used for MIC determinations against Capnocytophaga spp. The in vitro susceptibility of a large number of clinical isolates to recently developed drugs and drugs of known activity which might be useful either therapeutically or as selective agents in culture media was examined.
MATERIALS AND METHODS
Organisms. A total of 118 clinical isolates of Capnocytophaga spp. were tested in this study, and their respective sources of isolation are listed in Table 1 . A total of 45 strains were obtained from immunosuppressed patients; 73 were recovered from noncompromised persons. Of the latter, 26 strains were isolated from pocket samples taken from patients with severe periodontitis, and 25 strains were obtained from gingival scrapes of individuals without periodontitis.
Two reference strains were also included. One strain was confirmed as Capnocytophaga spp. at the Centers for Disease Control (Atlanta, Ga.) by R. Weaver; the second reference strain was identified as Capnocytophaga gingivalis by S. C. Holt, University of Massachusetts, Amherst. The strains were tested for the presence of beta-lactamase by a chromogenic cephalosporin (nitrocefin; Glaxo Pharmaceuticals Ltd., Greenford, United Kingdom) method (19) , revealing three strains that produced the enzyme. All strains were * Corresponding author. identified by standard methods described previously (21) 
